Cybin (TSE:CYBN) has released an update. Cybin has launched a pivotal Phase 3 program named PARADIGM to evaluate CYB003 as a treatment for Major Depressive Disorder, involving multiple studies across ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback